NCT07614568
Evaluating the Efficacy and Safety of Octane Aether for Treating Chronic Low Back Pain
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 4 more changesShow less
- Start date changed from estimate of Jun 2026 to Oct 15, 2026
- Eligibility criteria expanded, about 17 words
- Secondary endpoints: details revised at 2 of 7 entries
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Change in patient-reported pain scores during active treatment compared to the sham treatment period
Timeframe: From start of Treatment Period 1 (Week 2) to end of Treatment Period 4 (Week 9)
Secondary (7)
Adverse effects associated with the use of the Octane Aether
Effect of treatment on quality of life and disability index
Net change in perceived pain intensity (start to end)
Net effect of intervention on disability index
Effect of Octane Aether EMF treatment on general health (physical and emotional)
Show 2 moreShow less
Longevity of the effect of Octane Aether treatment
Longevity of the intervention effect on disability and quality of life
Arms and interventions
Sequence Group 1Experimental
Participants receive active/sham treatments in the following sequence: EMF A, EMF B, Sham, EMF C
Sequence Group 2Experimental
Participants receive active/sham treatments in the following sequence: EMF B, EMF C, EMF A, Sham
Sequence Group 3Experimental
Participants receive active/sham treatments in the following sequence: EMF C, Sham, EMF B, EMF A
Sequence Group 4Experimental
Participants receive active/sham treatments in the following sequence: Sham, EMF A, EMF C, EMF B
Devices: Pulsed electromagnetic field stimulator
Sites
1 site in 1 country
- Kingston Orthopaedic Pain InstituteKingston, Ontario, Canada